Egypt has received over 854,000 coronavirus vaccines through the Covax facility for lower and middle income countries, the World Health Organization said Thursday.
The AstraZeneca vaccines, the first to be provided through COVAX to Egypt, were delivered by plane to Cairo late Wednesday, WHO said in a statement.
Egypt has registered more than 200,000 cases of coronavirus, including some 12,000 deaths.
The health ministry has said frontline health workers, the elderly and people with chronic diseases will be prioritised in the vaccine effort, in line with global guidelines.
WHO said 40 million doses would be provided to Egypt—enough for 20 percent of the country’s 100 million population.
The Covax programme aims to help ensure 20 percent of the population in recipient countries is vaccinated by end-2021.
Egypt began its Covid-19 immunisation programme on January 24, becoming one of the first countries in Africa to begin vaccinating its citizens.
At a virtual press conference held by the WHO’s eastern Mediterranean division, officials acknowledged the organisation faced “challenges” in reaching its 20-percent target.
Difficulties included “creating lines of production… and other logistical challenges to deliver shipments to countries”, said Doctor Ahmed al-Mandhari, WHO’s regional director.
He cited in particular an absence of sufficient “storage facilities”, as some vaccines in the Covax programme—notably Pfizer’s—have to be kept at extremely low temperatures.
This was in addition to “funding and financial challenges”, as well as “competition by rich countries” for doses, a situation that the WHO has warned constrains the efficacy of overall efforts to defeat the mutating virus.
WHO officials pointed to the emergence of two new variants in war-torn Libya, warning they were likely to spread to both urban and rural areas.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
Egypt gets hundreds of thousands of vaccines via Covax (2021, April 1)
retrieved 1 April 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022